MAO inhibitors and their wider applications: a patent review

3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors

(2018) Priyanka Dhiman et al.   Current Neuropharmacology

Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease

(2017) Jacques Joubert et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Tranylcypromine in mind (Part I): Review of pharmacology

(2017) Sven Ulrich et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Use of monoamine oxidase inhibitors in chronic neurodegeneration

(2017) Peter Riederer et al.   Expert Opinion on Drug Metabolism & Toxicology

Coumarin derivatives: an updated patent review (2015-2016)

(2017) Anastasia Detsi et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?

(2017) André Fonseca et al.   JOURNAL OF MEDICINAL CHEMISTRY

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease

(2017) Edilio Borroni et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Different iron deposition patterns in early- and middle-late-onset Parkinson's disease

(2017) Min Xuan et al.   PARKINSONISM & RELATED DISORDERS

Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy

(2016) M Amélia Santos et al.   Future Medicinal Chemistry

Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies

(2016) Maria Concetta Gidaro et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Inhibition of Human Monoamine Oxidase: Biological and Molecular Modeling Studies on Selected Natural Flavonoids

(2016) Simone Carradori et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer

(2015) S Xu et al.   BRITISH JOURNAL OF CANCER

Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease

(2015) Sai-Sai Xie et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

New Frontiers in Selective Human MAO-B Inhibitors

(2015) Simone Carradori et al.   JOURNAL OF MEDICINAL CHEMISTRY

New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies

(2014) Celeste De Monte et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Safinamide for the treatment of Parkinson's disease

(2014) Livia Dézsi et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis

(2014) Jason Boyang Wu et al.   JOURNAL OF CLINICAL INVESTIGATION

Monoamine oxidases as sources of oxidants in the heart

(2014) Nina Kaludercic et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Aldehyde dehydrogenase (ALDH) in Alzheimer’s and Parkinson’s disease

(2014) Edna Grünblatt et al.   JOURNAL OF NEURAL TRANSMISSION

The role of iron in brain ageing and neurodegenerative disorders

(2014) Roberta J Ward et al.   LANCET NEUROLOGY

Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease

(2014) Rupam Borgohain et al.   MOVEMENT DISORDERS

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release

(2014) John P.M. Finberg   PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials

(2013) Chi-Un Pae et al.   CNS SPECTRUMS

Inhibitor Design for Monoamine Oxidases

(2013) Rona R. Ramsay   CURRENT PHARMACEUTICAL DESIGN

Monoamine Oxidases: The Biochemistry of the Proteins As Targets in Medicinal Chemistry and Drug Discovery

(2013) Rona R. Ramsay   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Selective MAO-B inhibitors: a lesson from natural products

(2013) Simone Carradori et al.   MOLECULAR DIVERSITY

Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression

(2012) Christopher T. Lum et al.   CNS SPECTRUMS

Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential

(2012) Simone Carradori et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Antidepressant-like effect of trans-resveratrol in chronic stress model: Behavioral and neurochemical evidences

(2012) Yingcong Yu et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives

(2011) Daniela Secci et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Flavonoids and the CNS

(2011) Anna Jäger et al.   MOLECULES

Focusing on new monoamine oxidase inhibitors

(2010) Adriana Bolasco et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Synthesis, Molecular Modeling, and Selective Inhibitory Activity against Human Monoamine Oxidases of 3-Carboxamido-7-Substituted Coumarins†

(2009) Franco Chimenti et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structural and Mechanistic Studies of Mofegiline Inhibition of Recombinant Human Monoamine Oxidase B∥

(2008) Erika M. Milczek et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors

(2008) S.-Y. Son et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA